Taken together, IFIT3 may serve as a novel therapeutic target for clearance of senescent cells and for blocking the production of type I IFN and other proinflammatory cytokines by the cGAS/STING signaling pathway in PBC. Here, IFIT3 is linked to primary biliary cholangitis.